Veru Inc (VERU)
1.35
-0.02
(-1.46%)
USD |
NASDAQ |
May 23, 12:25
Veru 1 Year Total Returns (Daily): 23.42% for May 22, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 22, 2024 | 23.42% |
| May 21, 2024 | 21.93% |
| May 20, 2024 | 24.56% |
| May 17, 2024 | 15.79% |
| May 16, 2024 | 26.85% |
| May 15, 2024 | 32.43% |
| May 14, 2024 | 28.95% |
| May 13, 2024 | 16.67% |
| May 10, 2024 | -10.74% |
| May 09, 2024 | 0.00% |
| May 08, 2024 | 4.38% |
| May 07, 2024 | 21.64% |
| May 06, 2024 | 22.39% |
| May 03, 2024 | 28.35% |
| May 02, 2024 | 30.16% |
| May 01, 2024 | 11.19% |
| April 30, 2024 | 6.30% |
| April 29, 2024 | -1.57% |
| April 26, 2024 | -0.78% |
| April 25, 2024 | -5.84% |
| April 24, 2024 | -5.71% |
| April 23, 2024 | -9.57% |
| April 22, 2024 | -9.93% |
| April 19, 2024 | 27.18% |
| April 18, 2024 | 37.86% |
| Date | Value |
|---|---|
| April 17, 2024 | 11.54% |
| April 16, 2024 | 25.50% |
| April 15, 2024 | 53.00% |
| April 12, 2024 | 52.00% |
| April 11, 2024 | 77.23% |
| April 10, 2024 | 24.00% |
| April 09, 2024 | 10.38% |
| April 08, 2024 | -2.83% |
| April 05, 2024 | -17.40% |
| April 04, 2024 | -25.23% |
| April 03, 2024 | -27.28% |
| April 02, 2024 | -33.26% |
| April 01, 2024 | -34.48% |
| March 28, 2024 | -46.15% |
| March 27, 2024 | -49.48% |
| March 26, 2024 | -55.80% |
| March 25, 2024 | -55.86% |
| March 22, 2024 | -60.14% |
| March 21, 2024 | -63.91% |
| March 20, 2024 | -65.80% |
| March 19, 2024 | -62.42% |
| March 18, 2024 | -64.52% |
| March 15, 2024 | -68.48% |
| March 14, 2024 | -71.01% |
| March 13, 2024 | -68.42% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.67%
Minimum
Aug 17 2023
474.8%
Maximum
Mar 16 2021
44.30%
Average
32.66%
Median
Oct 20 2022
1 Year Total Returns (Daily) Benchmarks
| EyePoint Pharmaceuticals Inc | 66.47% |
| INVO Bioscience Inc | -86.56% |
| Bio-Path Holdings Inc | -93.65% |
| Aileron Therapeutics Inc | 162.7% |
| ProKidney Corp | -63.84% |